Search
for
Sort by
Research 61–90 of 338
- Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies
- Adipokines in the Skin and in Dermatological Diseases
- Medical Dermatology
- Advances in Extraction Technologies of Silybum marianum L. and Its Role in Protecting Against Skin Damage
- Papulopustular eruptions associated with EGFR-pathway-related targeted therapies: clinical spectrum, evidence boundaries, folliculocentric inflammation, and management considerations
- PA11 A rare case of a severe papulopustular dermatosis secondary to a germline <i>EGFR</i> mutation
- PRIDE Complex (Papulopustules and/or Paronychia, Regulatory Abnormalities of Hair Growth, Itching, Dryness Due to EGFR Inhibitors)
- A linear and reticulate crusted keratotic papulopustular eruption: a rare presentation of PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) complex
- The PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) syndrome
- Histopathologic features of erythematous papulopustular eruption to epidermal growth factor receptor inhibitors in cancer patients
- Rosacea: I. Etiology, pathogenesis, and subtype classification
- Demodicosis and rosacea: Epidemiology and significance in daily dermatologic practice
- Isotretinoin treatment of acne and related disorders: An update
- Acne Resolution Rates: Results of a Single-Blind, Randomized, Controlled, Parallel Phase III Trial with EE/CMA (Belara<sup>®</sup>) and EE/LNG (Microgynon<sup>®</sup>)
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Azelaic Acid: Mechanisms of Action and Clinical Applications
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
- A distinct cutaneous reaction to sorafenib and a multikinase inhibitor
- Dermoscopic spectrum of rosacea
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
- Atypical folliculitis caused by Malassezia spp. in immunosuppressed patients
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Cutaneous Adverse Events of Targeted Anticancer Therapy: A Review of Common Clinical Manifestations and Management
- Mitigation of epidermal growth factor receptor inhibitor-induced side effects utilizing melanin and vascular-specific lasers: A case report series
- The management and treatment of acne
- Pyodermatitis vegetans associated with multiple myeloma
- Chemotherapy and Cutaneous Drug Reactions